Publications by authors named "Sheila Doggrell"

Claim this Profile
D
Does varenicline promote abstinence in youths who vape?
Sheila A Doggrell

Expert Opin Pharmacother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: reframing guselkumab's benefit in ulcerative colitis: insights from QUASAR and emerging evidence.
Sheila A Doggrell

Expert Opin Biol Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
With guselkumab, does the dual mechanisms to inhibit IL-23, help in ulcerative colitis?
Sheila A Doggrell

Expert Opin Biol Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are glucagon-like peptide-1 (GLP-1) receptor agonists useful in treating Parkinson's disease (PD)? Does the clinical trial with lixisenatide add anything?
Sheila A Doggrell

Expert Opin Investig Drugs· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Will elinzanetant, a neurokinin receptor antagonist, have a role in the treatment of hot flashes?
Sheila A Doggrell

Expert Opin Pharmacother· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Will zilebesiran, an RNA interference therapy, be effective, safe, and improve the treatment of hypertension?
Sheila A Doggrell

Expert Opin Biol Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Descriptive study showing the effect of small differences in entry scores on retention and success in six courses in nursing.
Sheila A Doggrell

BMC Nurs· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sibeprenlimab, which neutralizes A PRoliferation Inducing Ligand (APRIL), as a new approach to treating IgA nephropathy.
Sheila A Doggrell

Expert Opin Biol Ther· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
More failure with solanezumab - this time in preclinical Alzheimer's disease.
Sheila A Doggrell

Expert Opin Biol Ther· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences between students in various programs in a biochemistry course in lecture attendance, engagement, and academic outcomes.
Sheila Anne Doggrell

Biochem Mol Biol Educ· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bempedoic acid as treatment for subjects at cardiovascular risk who are statin-intolerant.
Sheila A Doggrell

Expert Opin Pharmacother· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous subcutaneous levodopa-carbidopa for the treatment of advanced Parkinson's disease: is it an improvement on other delivery?
Sheila A Doggrell

Expert Opin Drug Deliv· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retatrutide showing promise in obesity (and type 2 diabetes).
Sheila A Doggrell

Expert Opin Investig Drugs· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is sotatercept, which traps activins and growth differentiation factors, a new dawn in treating pulmonary arterial hypertension (PAH)?
Sheila A Doggrell

Expert Opin Biol Ther· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is retatrutide (LY3437943), a GLP-1, GIP, and glucagon receptor agonist a step forward in the treatment of diabetes and obesity?
Sheila A Doggrell

Expert Opin Investig Drugs· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follow-up descriptive study of how proportioning marks between coursework and examination affects the performance of students in nursing.
Sheila A Doggrell

BMC Nurs· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new role for an old drug: acetazolamide in decompensated heart failure.
Sheila A Doggrell

Expert Opin Pharmacother· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ULTIMATE trials: are there advantages of ublituximab over teriflunomide in relapsing multiple sclerosis?
Sheila A Doggrell

Expert Opin Biol Ther· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are there advantages of daprodustat over erythropoiesis-stimulating agents (ESAs) in treating anemia associated with chronic kidney disease (CKD)?
Sheila A Doggrell

Expert Opin Pharmacother· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adding liraglutide to diet and exercise to maintain weight loss - is it worth it?
Sheila A Doggrell

Expert Opin Pharmacother· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative study of lecture attendance and the association between this attendance and academic outcomes for nursing and nonnursing students in an introductory pathophysiology course.
Sheila A Doggrell

Adv Physiol Educ· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do we need bamlanivimab? Is etesevimab a key to treating Covid-19?
Sheila A Doggrell

Expert Opin Biol Ther· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Still grasping at straws: donanemab in Alzheimer's disease.
Sheila A Doggrell

Expert Opin Investig Drugs· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Finerenone - are we there yet with a non-steroidal mineralocorticoid receptor antagonist for the treatment of diabetic chronic kidney disease?
Sheila A Doggrell

Expert Opin Pharmacother· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative study showing how and why students access lecture recordings, and of the association between accessing and academic outcomes, in a biochemistry course.
Sheila Anne Doggrell

Biochem Mol Biol Educ· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis